Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $15.0 million.

  • Aspen Aerogels' Cash from Operations fell 2761.54% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.4 million, marking a year-over-year increase of 63978.27%. This contributed to the annual value of $45.5 million for FY2024, which is 20689.24% up from last year.
  • According to the latest figures from Q3 2025, Aspen Aerogels' Cash from Operations is $15.0 million, which was down 2761.54% from -$3.9 million recorded in Q2 2025.
  • Aspen Aerogels' 5-year Cash from Operations high stood at $35.7 million for Q4 2024, and its period low was -$37.5 million during Q3 2022.
  • Moreover, its 5-year median value for Cash from Operations was -$6.0 million (2021), whereas its average is -$4.9 million.
  • As far as peak fluctuations go, Aspen Aerogels' Cash from Operations tumbled by 111949.79% in 2022, and later soared by 138405.9% in 2024.
  • Aspen Aerogels' Cash from Operations (Quarter) stood at -$12.0 million in 2021, then tumbled by 99.85% to -$24.1 million in 2022, then surged by 88.46% to -$2.8 million in 2023, then surged by 1384.06% to $35.7 million in 2024, then tumbled by 57.87% to $15.0 million in 2025.
  • Its Cash from Operations was $15.0 million in Q3 2025, compared to -$3.9 million in Q2 2025 and $5.6 million in Q1 2025.